Medipost Co (XKRX:078160) EV-to-Revenue : 1.36 (As of Apr. 30, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Medipost Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Medipost Co's enterprise value is ₩93,167 Mil. Medipost Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩68,643 Mil. Therefore, Medipost Co's EV-to-Revenue for today is 1.36.

The historical rank and industry rank for Medipost Co's EV-to-Revenue or its related term are showing as below:

XKRX:078160' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.86 Med: 10.58 Max: 39.79
Current: 1.36

During the past 13 years, the highest EV-to-Revenue of Medipost Co was 39.79. The lowest was 0.86. And the median was 10.58.

XKRX:078160's EV-to-Revenue is ranked better than
84.04% of 1034 companies
in the Biotechnology industry
Industry Median: 7.775 vs XKRX:078160: 1.36

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-30), Medipost Co's stock price is ₩7090.00. Medipost Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,178.31. Therefore, Medipost Co's PS Ratio for today is 2.23.

Medipost Co EV-to-Revenue Historical Data

The historical data trend for Medipost Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co EV-to-Revenue Chart

Medipost Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

11.19

10.70

5.84

2.63

1.93

Medipost Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															2.63	2.55	2.62	1.05	1.93

Competitive Comparison of Medipost Co's EV-to-Revenue

For the Biotechnology subindustry, Medipost Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medipost Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medipost Co's EV-to-Revenue falls into.

Medipost Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Medipost Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	93166.869	/	68642.986
	=	1.36

Medipost Co's current Enterprise Value is ₩93,167 Mil.
Medipost Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩68,643 Mil.

Medipost Co (XKRX:078160) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Medipost Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	7090.00	/	3178.305
	=	2.23

Medipost Co's share price for today is ₩7090.00.
Medipost Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,178.31.

Medipost Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medipost Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipost Co (XKRX:078160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (XKRX:078160) Headlines

No Headlines